HCP Connect Clinical Author
Dr. Aditi Kulkarni
Neurology
Specialty
Neurology
Clinical Updates
13
Experience
5 Years
Author Biography
About Dr. Aditi Kulkarni
Dr. Aditi Kulkarni is a neurologist with 5 years of clinical experience. She holds a DM in Neurology following an MD in General Medicine, with a focus on headache disorders, multiple sclerosis, and neuroimmunology. She is drawn to advances in disease-modifying therapies. Her writing makes evolving neurology evidence clear and usable.
Published Work
Recent Clinical Updates
13 articles
Neurology
Oveporexton: Increases Wakefulness (MWT) 25.4 min in Narcolepsy Type 1
Oveporexton narcolepsy type 1 phase 2: mean MWT increases to 25.4 min vs â1.2 min at week 8; ESS and cataplexy improved (NEJM) [1].
Neurology
FDA Approves Leucovorin for Cerebral Folate Transport Deficiency
Leucovorin approved for cerebral folate transport deficiency (FOLR1-CFTD); FDA cleared first treatment with weight-based dosing guidance for adults and pediatric patients.
Neurology
FDA Approves Glatiramer Acetate for Relapsing MS: HR 0.55 in Study 3
Glatiramer acetate relapsing multiple sclerosis: FDA approval and Study 3 result (HR 0.55).
Neurology
efgartigimod: 68% MGâADL Response in ADAPT; SubQ VYVGART HYTRULO Dosing
efgartigimod myasthenia gravis: ADAPT showed 68% MGâADL response in AChRâpositive patients; VYVGART HYTRULO offers subcutaneous dosing per label.
Neurology
FDA Approves Subcutaneous Lecanemab: CDRâSB â0.45 in CLARITY AD
lecanemab Alzheimer disease treatment: FDA added subcutaneous 360 mg weekly maintenance (IQLIK) after 18 months; CLARITY AD showed CDRâSB â0.45 vs placebo.
Neurology
FDA Approves donanemab for Alzheimer: iADRS Benefit 2.92 Points
Donanemab (KISUNLA) FDA approval for Alzheimer disease: iADRS 2.92-point benefit, dosing, ARIA risks, and imagingâguided therapy.
Medical Research
Type 2 Diabetes Linked to Faster Chronic Disease Onset
New research reveals type 2 diabetes accelerates development of multiple chronic diseases, particularly in middle-aged adults, impacting patient outcomes and treatment plans.
Medical Research
Emotional Eaters Less Likely to Lose Weight on GLP-1 Therapy
Research reveals individuals who overeat for emotional reasons may have reduced weight loss success with GLP-1 receptor agonists like Ozempic.
Healthcare Business
Reduce Mental Fatigue in Hearing Loss Patients by 30%
Discover how addressing hearing loss can improve mental health outcomes, reducing social isolation, anxiety, and depression in patients.
Neurology
Boost Neurology Dept Efficiency with Effective Vice Chair Roles
Discover how evolving vice chair responsibilities can enhance neurology department leadership, faculty engagement, and alignment with institutional goals.
Health Information
Accurate RA Diagnosis in Less Time
Learn how lab tests and imaging help doctors diagnose rheumatoid arthritis quickly and accurately, reducing diagnostic time and improving patient outcomes.
Medical Devices
Boost Breast Cancer Survival Rates with Latest Treatments
Discover how advances in breast cancer treatment are improving patient outcomes and survival rates, offering new hope for individuals diagnosed with the disease.
Medical Research
FDA May Drop Expert Reviews, Impacting Drug Approval
Proposed FDA policy change could reduce public scrutiny of new drug approvals, what it means for physicians and patient care decisions.